NeuPath Health Inc
XTSX:NPTH

Watchlist Manager
NeuPath Health Inc Logo
NeuPath Health Inc
XTSX:NPTH
Watchlist
Price: 0.46 CAD
Market Cap: CA$25.8m

Wall Street
Price Targets

NPTH Price Targets Summary
NeuPath Health Inc

Wall Street analysts forecast NPTH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NPTH is 0.51 CAD with a low forecast of 0.51 CAD and a high forecast of 0.53 CAD.

Lowest
Price Target
0.51 CAD
10% Upside
Average
Price Target
0.51 CAD
11% Upside
Highest
Price Target
0.53 CAD
14% Upside
NeuPath Health Inc Competitors:
Price Targets
PHVS
Pharvaris NV
80% Upside
CNC
Concurrent Technologies PLC
40% Upside
BLFS
BioLife Solutions Inc
74% Upside

Revenue
Forecast

10% / Year
Past Growth
23% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
10% / Year
Past Growth
23% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 6 years the compound annual growth rate for NeuPath Health Inc's revenue is 10%. The projected CAGR for the next 1 year is 23%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
NeuPath Health Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NPTH's stock price target?
Price Target
0.51 CAD

According to Wall Street analysts, the average 1-year price target for NPTH is 0.51 CAD with a low forecast of 0.51 CAD and a high forecast of 0.53 CAD.

What is NeuPath Health Inc's Revenue forecast?
Projected CAGR
23%

For the last 6 years the compound annual growth rate for NeuPath Health Inc's revenue is 10%. The projected CAGR for the next 1 year is 23%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett